Astellas to Move Clinical Development Base to U.S.
TOKYO, Mar 4, 2008 (Jiji Press) - Japanese drug maker Astellas Pharma Inc. said Tuesday it will set up a new company in the U.S. state of Illinois in April to oversee the clinical development activities of its group as a whole.
The transfer of Astellas' clinical development base, currently located in Japan, is aimed at speeding up decision-making and boosting market competitiveness, the company said.
The new firm will be named Astellas Pharma Global Development Inc.
Recently, a growing number of Japanese drug makers have transferred their research and development bases to locations outside Japan, reflecting a slowdown in the domestic market and increased dependence on overseas sales.
Posted: March 2008
